Hjem › Venstriket dysfunktion › New York
Venstriket dysfunktion kliniske forsøg i New York
4 studier for Venstriket dysfunktion søger deltagere på steder i New York.
Byer i New York
Officiel studietekst (engelsk)
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Columbia University Medical Center-Pediatric Cardiology ( Site 0016), New York
- The Children's Hospital at Montefiore ( Site 0030), The Bronx
RekruttererFase 2/3
29 Days – 17 Years · Alle køn · Opdateret 28. aug. 2026 · NCT05714085A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Icahn School of Medicine at Mount Sinai - Pediatric Cardiology, New York
- Columbia University Irving Medical Center - Pediatric Cardiology, New York
- The Children's Hospital at Montefiore - Cardiology, The Bronx
RekruttererFase 3
Op til 18 år · Alle køn · Opdateret 29. jun. 2026 · NCT07192952A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Icahn School of Medicine at Mount Sinai - Pediatric Cardiology, New York
- Columbia University Irving Medical Center - Pediatric Cardiology, New York
- The Children's Hospital at Montefiore - Cardiology, The Bronx
RekruttererFase 3
6 Months – 17 Years · Alle køn · Opdateret 15. jun. 2026 · NCT07188805AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
- Mount Sinai Hospital, New York
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 1. jun. 2026 · NCT06699056Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.